LUCD logo

LUCD
Lucid Diagnostics Inc

1,906
Mkt Cap
$161.25M
Volume
1.02M
52W High
$1.80
52W Low
$0.8804
PE Ratio
-1.36
LUCD Fundamentals
Price
$1.22
Prev Close
$1.23
Open
$1.23
50D MA
$1.11
Beta
0.59
Avg. Volume
692,970.45
EPS (Annual)
-$1.05
P/B
-5.62
Rev/Employee
$60,361.11
Loading...
Loading...
News
all
press releases
Perkins Capital Management Inc. Invests $1.14 Million in Lucid Diagnostics Inc. $LUCD
Perkins Capital Management Inc. purchased a new stake in shares of Lucid Diagnostics Inc. (NASDAQ:LUCD - Free Report) in the 3rd quarter, according to its most recent filing with the Securities...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
What's Going On With PAVmed Shares Thursday?
PAVmed shares pull back Thursday, possibly retracing recent gains on news its subsidiary, Lucid Diagnostics secured a contractread more...
Benzinga·6d ago
News Placeholder
Why Is PAVmed Stock Skyrocketing Wednesday?
PAVmed Inc. (PAVM) surges as its subsidiary Lucid Diagnostics (LUCD) secures a contract with VA for its cancer prevention test.read more...
Benzinga·7d ago
News Placeholder
PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs?
The company’s subsidiary, Lucid Diagnostics, secured a contract from the U.S. Department of Veterans Affairs to provide its EsoGuard Esophageal DNA Test for the detection of esophageal precancer.
Stocktwits·7d ago
News Placeholder
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard PR Newswire NEW YORK, Jan. 21...
PR Newswire·7d ago
News Placeholder
Lucid Diagnostics (NASDAQ:LUCD) Stock Price Up 0.9% - Here's Why
Lucid Diagnostics (NASDAQ:LUCD) Trading 0.9% Higher - Should You Buy...
MarketBeat·22d ago
News Placeholder
PAVmed Announces Reverse Stock Split
PAVmed Announces Reverse Stock Split PAVmed Announces Reverse Stock Split PR Newswire NEW YORK, Dec. 30, 2025 NEW YORK, Dec. 30, 2025 /PRNewswire/ --PAVmed Inc.(NASDAQ: PAVM) ('PAVmed' or the...
PR Newswire·29d ago
News Placeholder
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Lucid Diagnostics Inc. (NASDAQ:LUCD - Get Free Report) has been given an average rating of "Moderate Buy" by the five brokerages that are covering the company, MarketBeat reports. One equities...
MarketBeat·1mo ago
News Placeholder
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection Lucid Diagnostics Announces Positive Data from the Largest Reported...
PR Newswire·2mo ago
News Placeholder
Wednesday Sector Laggards: Diagnostics, Medical Instruments & Supplies
In trading on Wednesday, diagnostics shares were relative laggards, down on the day by about 0.4%. Helping drag down the group were shares of Nutex Health, off about 5.7% and shares of Lucid...
Nasdaq News: Markets·2mo ago
<
1
2
...
>

Latest LUCD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.